Use this URL to cite or link to this record in EThOS:
Title: Synthesis of agents potentially useful in cancer chemotherapy
Author: Barnes, John George
ISNI:       0000 0004 2718 0101
Awarding Body: University of Manchester
Current Institution: University of Manchester
Date of Award: 2011
Availability of Full Text:
Access from EThOS:
Access from Institution:
A range of novel, potent, inhibitors of NAD(P)H quinone oxidoreductase 1 (NQO1) and NAD(P)H quinone oxidoreductase 2 (NQO2) were synthesised. The therapeutic utility of this could be three-fold: 1) Impairing tumour growth.2) Promoting the transient degradation of the p53 tumour suppressor protein in cells can enhance the activity of conventional anti-cancer drugs. 3) For probing the effects of NQO1 or NOQ2 inhibition within cells. The potential inhibitors were classified as three distinct groups based on the core structure, known as the triazoloacridinones (31), imidazoacridinones (131), and 4-hydroxycoumarins (182 - 195, 197 - 210). The syntheses of the triazoloacridinones (31) and imidazoacridinones (131) were achieved through divergent synthetic routes, so that a large variety of compounds could be made quickly, and economically. A selection of these were then modified to increase potency, improve water solubility, and lower toxicity. The final 4-hydroxycoumarin series (183, 190, 192, 199, 201, 215, 216) was first produced using existing methods. Later, a more desirable route was developed using the 'borrowing hydrogen' methodology, to improve upon the efficiency and yield. All three families of compounds were found to contain potent, nanomolar inhibitors of NQO1 and NQO2, which could inhibit the enzymes in cells, at non-toxic concentrations.
Supervisor: Stratford, Ian ; Whitehead, Roger Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available